Cisatracurium Besylate Injection

What is Cisatracurium Besylate Injection?
Cisatracurium Besylate Injection is an intermediate-acting neuromuscular blocking agent (NMBA). As an isomer of atracurium, it is widely used during surgery and in critical care environments to provide skeletal muscle relaxation. It is particularly favored in clinical settings because it does not trigger a significant release of histamine, making it a safer profile for patients with cardiovascular sensitivities compared to other muscle relaxants.
Uses of Cisatracurium Besylate Injection
Surgical Muscle Relaxation: Facilitates both major and minor surgical procedures by inducing muscle paralysis.
Endotracheal Intubation: Relaxes the laryngeal and abdominal muscles to allow for smooth insertion of a breathing tube.
Mechanical Ventilation: Used in the Intensive Care Unit (ICU) to facilitate long-term ventilation in critically ill patients.
Maintenance of Anesthesia: Used as an adjunct to general anesthesia to maintain a quiet surgical field.
ICU Sedation Adjunct: Used when profound paralysis is needed to manage patients with severe respiratory failure (e.g., ARDS).
How Does Cisatracurium Besylate Injection Work?
Cisatracurium works as a competitive antagonist at the nicotinic acetylcholine receptors of the neuromuscular junction. By binding to these receptors, it prevents acetylcholine from transmitting signals from the motor nerves to the muscles. This results in the temporary cessation of muscle contraction. One of its unique advantages is Hofmann elimination, a process where the drug breaks down naturally in the body's pH and temperature, making its clearance independent of organ (liver or kidney) function.
FAQs on Cisatracurium Besylate Injection
1. Why is Cisatracurium preferred for patients with kidney or liver issues? Because Cisatracurium undergoes Hofmann elimination, its metabolism does not rely on the liver or kidneys. This makes it the drug of choice for patients with multi-organ failure or impaired renal and hepatic function, as the risk of prolonged paralysis is significantly reduced.
2. Does Cisatracurium provide pain relief or sedation? No. Like all neuromuscular blockers, Cisatracurium only paralyzes muscles. It does not provide analgesia (pain relief) or sedation. It must always be administered to a patient who is already adequately anesthetized or sedated to prevent the distress of being awake but unable to move.
3. What is the typical duration of action for this injection? Cisatracurium is considered an intermediate-acting agent. After a standard intubation dose, the effective relaxation typically lasts for about 45 to 60 minutes, with a gradual recovery thereafter.
Therapeutic Category
Others (Neuromuscular Blocker)
Looking for a reliable Cisatracurium Besylate Injection manufacturer? Contact Farbe Firma Pvt. Ltd. for dossier support, registration assistance, and export supplies. We specialize in high-purity sterile injectables and specialized anesthetic agents for the global healthcare market.